Neuphoria Therapeutics NEUP Institutional Ownership

NASDAQ NEUP

$3.56 -0.01 (-0.28%)

At close: Sep 30, 2026 · 4:00 PM EDT

Institutions by Trading Activity

22 Institutions

Increased 12 54.5%

Unchanged 8 36.4%

Reduced 2 9.1%

Ownership Statistics

13F · as of 30 Jun, 2026

Institutional Ownership

1.60%

▲+0.30 pp QoQ

Shares Held by Institutions

1.99Mn

of 124.66Mn outstanding

▲+29.75% QoQ

Shares Outstanding

124.66Mn

122.67Mn held outside 13F filers

Institutional Investors

filed 13F for Jun 2026

▲+5 vs prior quarter

Net Shares Added (QoQ)

+457.20K

accumulated since last quarter

Value of Holdings

$7.10Mn

reported market value

Shares Owned by Institutions

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Institutions

Accumulated Distributed

Latest quarter —

Net over range —

Accumulating quarters —

Ownership Summary

Quarter ending 30 Jun, 2026

Neuphoria Therapeutics Inc. (NASDAQ:NEUP) showed up in the 13F filings of 22 institutional investors as of June 2026.

These investors collectively held 1.6% of Neuphoria Therapeutics's outstanding shares in June 2026, up from 1.3% in March 2026.
They increased total shares held in NEUP by 29.75% quarter over quarter, and investors in Neuphoria Therapeutics increased 175.0% from a year ago.
Of these 22 funds, 12 grew their exposure to Neuphoria Therapeutics, 2 cut back, and 8 maintained positions.
The aggregate institutional position in Neuphoria Therapeutics amounted to 1.99Mn shares as of June 2026, up by 457.2K shares quarter on quarter, and up 1.83Mn shares year over year.
As of June 30, 2026, Lynx1 Capital Management LP held the largest stake in Neuphoria Therapeutics with 875.33K shares, accounting for 0.7% of total shares outstanding.
Leading buyers of Neuphoria Therapeutics shares for the quarter ending June 2026 were VANGUARD CAPITAL MANAGEMENT LLC (173.49K), AdvisorShares Investments LLC (97.54K), CITADEL ADVISORS LLC (53.23K), VANGUARD FIDUCIARY TRUST CO (33.81K), RENAISSANCE TECHNOLOGIES LLC (25.5K).
The biggest sellers of Neuphoria Therapeutics for the quarter ending June 2026 included GEODE CAPITAL MANAGEMENT, LLC (2.49K), UBS Group AG (199).
Neuphoria Therapeutics's 10 largest shareholders as of June 2026 include Lynx1 Capital Management LP (875.33K), AdvisorShares Investments LLC (252.91K), VANGUARD CAPITAL MANAGEMENT LLC (173.49K), Shay Capital LLC (155.82K), BALYASNY ASSET MANAGEMENT L.P. (142.23K), CITADEL ADVISORS LLC (72.56K), GEODE CAPITAL MANAGEMENT, LLC (49.52K), Ikarian Capital, LLC (47.44K), VANGUARD FIDUCIARY TRUST CO (33.81K), ADAR1 Capital Management, LLC (30.0K) per Business Quant data.

Form 13F Holdings

22 Institutional Holders

Report period 30 Jun, 2026

Total shares held 1.99Mn

Of outstanding 1.60%

#	Institution	CIK	Shares Held	% of Outstanding	Change (QoQ)	Change (%)	Value (USD)
1	Lynx1 Capital Management LP	0001910456	875,328	0.70%	0	0.00%	$3.83Mn
2	AdvisorShares Investments LLC	0001425930	252,909	0.20%	▲97,542	+62.78%	$1.11Mn
3	VANGUARD CAPITAL MANAGEMENT LLC	0002100119	173,488	0.14%	▲173,488	0.00%	$758.14K
4	Shay Capital LLC	0001723643	155,822	0.12%	▲4,812	+3.19%	$680.94K
5	BALYASNY ASSET MANAGEMENT L.P.	0001218710	142,228	0.11%	▲45	+0.03%	$621.54K
6	CITADEL ADVISORS LLC	0001423053	72,559	0.06%	▲53,228	+275.35%	$317.08K
7	GEODE CAPITAL MANAGEMENT, LLC	0001214717	49,516	0.04%	▼2,491	-4.79%	$216.38K
8	Ikarian Capital, LLC	0001778253	47,443	0.04%	0	0.00%	$207.33K
9	VANGUARD FIDUCIARY TRUST CO	0000933478	33,806	0.03%	▲33,806	0.00%	$147.73K
10	ADAR1 Capital Management, LLC	0001940272	30,000	0.02%	0	0.00%	$131.10K
11	FNY Investment Advisers, LLC	0001742998	26,500	0.02%	0	0.00%	$115
12	RENAISSANCE TECHNOLOGIES LLC	0001037389	25,500	0.02%	▲25,500	0.00%	$111.44K
13	XTX Topco Ltd	0001828301	23,089	0.02%	▲23,089	0.00%	$100.90K
14	HRT FINANCIAL LP	0001475597	22,865	0.02%	▲22,865	0.00%	$99
15	JANE STREET GROUP, LLC	0001595888	14,903	0.01%	▲14,903	0.00%	$65.13K
16	BOOTHBAY FUND MANAGEMENT, LLC	0001549230	14,000	0.01%	0	0.00%	$61.18K
17	COMMONWEALTH EQUITY SERVICES, LLC	0000312272	11,222	0.01%	0	0.00%	$49.04K
18	Northern Trust Corp	0000073124	10,610	0.01%	▲10,610	0.00%	$46.37K
19	Merck & Co., Inc.	0000310158	10,027	0.01%	0	0.00%	$43.82K
20	UBS Group AG	0001610520	2,117	0.00%	▼199	-8.59%	$9.25K

Showing 1 to 20 of 22 holders